Baskota Swikrity Upadhyay, Chandra Ashish, Cross Paul
Department of Pathology, University of Pittsburgh Medical Center Pittsburgh, PA, USA.Conflicts of interest: none declared.
, Consultant Cellular Pathologist, Department of Pathology, St.Thomas' Hospital, London, UK.Conflicts of interest: none declared.
Diagn Histopathol (Oxf). 2021 Mar;27(3):116-122. doi: 10.1016/j.mpdhp.2020.10.007. Epub 2020 Oct 12.
This paper reviews the challenges faced by cytology laboratories during the COVID-19 pandemic. Various safety guidelines regarding collection, handling, transport and sampling in cytology laboratory are presented. A brief literature overview of adapted changes regarding new safety techniques, processing, sampling techniques implemented by the cytology laboratories in this part of the world is presented. The use of cytology in COVID-19 patients is discussed. The authors have also tried to present the challenges and changes faced for training and education during this time. Migration from multi-headed scope in-person sign-out to digital based platforms were adapted to continue medical education. The potential long-term implications of these adaptations on cytology services are also touched upon.
本文回顾了细胞学实验室在新冠疫情期间所面临的挑战。文中介绍了细胞学实验室在样本采集、处理、运输和取样方面的各项安全指南。简要概述了世界该地区细胞学实验室在实施新安全技术、处理方法、取样技术方面所做的适应性变化的文献。讨论了细胞学在新冠患者中的应用。作者还试图阐述在此期间培训和教育所面临的挑战与变化。从多人现场阅片签字改为采用数字化平台,以继续医学教育。文中也提及了这些调整对细胞学服务可能产生的长期影响。